MORGAN STANLEY PLC/CALL/VEEVA SYSTEM/200/0.1/20.12.24 Stock

Warrant

DE000MB35LP9

Market Closed - Börse Stuttgart 14:59:17 2024-06-07 EDT
1.15 EUR +1.77% Intraday chart for MORGAN STANLEY PLC/CALL/VEEVA SYSTEM/200/0.1/20.12.24
Current month+39.51%
1 month-53.88%
Date Price Change
24-06-07 1.15 +1.77%
24-06-06 1.13 +4.63%
24-06-05 1.08 +22.73%
24-06-04 0.88 +17.33%
24-06-03 0.75 -7.41%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 02:59 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying VEEVA SYSTEMS INC.
Issuer Morgan Stanley
WKN MB35LP
ISINDE000MB35LP9
Date issued 2023-02-02
Strike 200 $
Maturity 2024-12-20 (196 Days)
Parity 10 : 1
Emission price 3.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.26
Lowest since issue 0.7
Spread 0.04
Spread %3.36%

Company Profile

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company’s three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.
Sector
-
More about the company

Ratings for Veeva Systems Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Veeva Systems Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
183.1 USD
Average target price
223.3 USD
Spread / Average Target
+21.94%
Consensus